Literature DB >> 11816385

Geniculate neuralgia: long-term results of surgical treatment.

Jack L Pulec1.   

Abstract

A rare cause of otalgia is geniculate neuralgia. In its most typical form, it is characterized by severe paroxysmal neuralgic pain centered directly in the ear. The pain can be of a gradual onset and of a dull, persistent nature, but occasionally it is sharp and stabbing. When the pain becomes intractable, an operation to surgically excise the nervus intermedius and geniculate ganglion via the middle cranial fossa approach is indicated. The purpose of this article is to review the long-term outcomes in 64 patients who were treated in this manner. Findings indicate that excision of the nervus intermedius and geniculate ganglion can be routinely performed without causing facial paralysis and that it is an effective definitive treatment for intractable geniculate neuralgia.

Entities:  

Mesh:

Year:  2002        PMID: 11816385

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  4 in total

1.  Paroxysmal otalgia treated with microvascular decompression of the intermediate nerve: illustrative case.

Authors:  Leonie Witters; Anton Lukes; Tomas Menovsky
Journal:  J Neurosurg Case Lessons       Date:  2021-05-10

2.  Microvascular decompression of the posterior inferior cerebellar artery for intermediate nerve neuralgia.

Authors:  Humberto Kluge Schroeder; Iuri Santana Neville; Daniel Ciampi de Andrade; Guilherme Alves Lepski; Manoel Jacobsen Teixeira; Kleber Paiva Duarte
Journal:  Surg Neurol Int       Date:  2015-04-01

3.  Nervus Intermedius Neuralgia Treated with Microvascular Decompression: A Case Report and Review of the Literature.

Authors:  Takuro Inoue; Ayako Shima; Hisao Hirai; Fumio Suzuki; Masayuki Matsuda
Journal:  NMC Case Rep J       Date:  2017-06-08

4.  Case Report: Direct Visualization of the Nervus Intermedius During the Microvascular Decompression Procedure: Should We Take It Seriously?

Authors:  Rui-Zhe Zheng; Chang-Yi Zhao; Zhi-Jie Zhao; Xin-Yuan Li
Journal:  Front Neurol       Date:  2021-06-09       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.